Inotrem is a clinical stage biotechnology company specialized in immunotherapy. The company has developed a new concept of immunomodulation that targets TREM-1 to control unbalanced inflammatory responses.
peer of
Metrics
marketPRIVATE
msh_idCOM:INOTREM
localefr
websitehttps://www.inotrem.com
source_ref4bc26ca1-cd93-4e98-814f-502992ecba18
products_or_servicesImmunotherapy products focused on TREM-1 pathway for the treatment of acute and chronic inflammatory diseases.
France